Gene · 3738
Papers2,009
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,009
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Molecular mapping of KCNE4-dependent regulation of Kv1.3. | Am J Physiol Cell Physiol | 2024 | 39466181 | PubTator, text mining | PubMed |
| Involvement of different K+ channel subtypes in hydrogen sulfide-induced vasorelaxation of human internal mammary artery. | Fundam Clin Pharmacol | 2024 | 39246043 | PubTator, text mining | PubMed |
| BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway. | Sci Adv | 2024 | 39231216 | PubTator, text mining | PubMed |
| Polymodal K+ channel modulation contributes to dual analgesic and anti-inflammatory actions of traditional botanical medicines. | Commun Biol | 2024 | 39198706 | PubTator, text mining | PubMed |
| Far-Red Fluorescent Proteins: Tools for Advancing In Vivo Imaging. | Biosensors (Basel) | 2024 | 39194588 | PubTator, text mining | PubMed |
| Novel insights into the modulation of the voltage-gated potassium channel KV1.3 activation gating by membrane ceramides. | J Lipid Res | 2024 | 39019344 | PubTator, text mining | PubMed |
| The role of potassium ion channels in chronic sinusitis. | Front Pharmacol | 2024 | 39015366 | PubTator, text mining | PubMed |
| Kv1.3-induced hyperpolarization is required for efficient Kaposi's sarcoma-associated herpesvirus lytic replication. | Sci Signal | 2024 | 39012937 | PubTator, text mining | PubMed |
| Clarithromycin attenuates airway epithelial-mesenchymal transition in ovalbumin-induced asthmatic mice through modulation of Kv1.3 channels and PI3K/Akt signaling. | Int Immunopharmacol | 2024 | 39002519 | PubTator, text mining | PubMed |
| Characterization and modulation of voltage-gated potassium channels in human lymphocytes in schizophrenia. | Schizophr Res | 2024 | 38944972 | PubTator, text mining | PubMed |
| Proximity Labeling Proteomics Reveals Kv1.3 Potassium Channel Immune Interactors in Microglia. | Mol Cell Proteomics | 2024 | 38936775 | PubTator, text mining | PubMed |
| 3,3',4,4'-tetrachlorobiphenyl (PCB77) enhances human Kv1.3 channel currents and alters cytokine production. | Korean J Physiol Pharmacol | 2024 | 38926840 | PubTator, text mining | PubMed |
| Newly Identified KCNA3 Gene Variants Put the "Excite"-ment Back in Kv1.3 Channelopathy. | Epilepsy Curr | 2024 | 38898907 | PubTator, text mining | PubMed |
| Non-invasive diagnosis of esophageal cancer by a simplified circulating cell-free DNA methylation assay targeting OTOP2 and KCNA3: a double-blinded, multicenter, prospective study. | J Hematol Oncol | 2024 | 38890756 | PubTator, text mining | PubMed |
| KCNE4-dependent modulation of Kv1.3 pharmacology. | Biochem Pharmacol | 2024 | 38880360 | PubTator, text mining | PubMed |
| Effects of Kv1.3 knockout on pyramidal neuron excitability and synaptic plasticity in piriform cortex of mice. | Acta Pharmacol Sin | 2024 | 38862816 | PubTator, text mining | PubMed |
| Regulation of T Lymphocyte Functions through Calcium Signaling Modulation by Nootkatone. | Int J Mol Sci | 2024 | 38791278 | PubTator, text mining | PubMed |
| Synthetic ShK-like Peptide from the Jellyfish Nemopilema nomurai Has Human Voltage-Gated Potassium-Channel-Blocking Activity. | Mar Drugs | 2024 | 38786608 | PubTator, text mining | PubMed |
| Sphingosine is involved in PAPTP-induced death of pancreas cancer cells by interfering with mitochondrial functions. | J Mol Med (Berl) | 2024 | 38780771 | PubTator, text mining | PubMed |
| Voltage-gated potassium channel 1.3: A promising molecular target in multiple disease therapy. | Biomed Pharmacother | 2024 | 38692062 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3738/papers?page=6